Results 271 to 280 of about 144,049 (286)

Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials

Lancet, The, 2021
E Guttman-Yassky, Ka Papp, Andrew Blauvelt   +2 more
exaly  

Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial

Lancet, The, 2003
Marko Kalliomäki, Seppo Salminen
exaly  

Development of allergen-specific T-cell memory in atopic and normal children

Lancet, The, 1999
Susan L Prescott, Patrick G Holt
exaly  

Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial

Lancet, The, 2017
Andrew Blauvelt, Marjolein de Bruin-Weller, Melinda Gooderham   +2 more
exaly  

Atopic Dermatitis

Pediatric Clinics of North America, 1983
openaire   +2 more sources

Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial

Lancet, The, 2001
Marko Kalliomäki, Seppo Salminen, Erika Isolauri   +2 more
exaly  

Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial

Lancet, The, 2016
Thomas Bieber, Andrew Blauvelt, Margitta Worm   +2 more
exaly  

Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC

Lancet, The, 1998
Richard Beasley MBChB
exaly  

Atopic Dermatitis

Archives of Dermatology, 1979
openaire   +2 more sources

ATOPIC DERMATITIS

The American Journal of the Medical Sciences, 1966
L M, Solomon, H, Beerman
openaire   +2 more sources